Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Is Paxlovid Any Better Than Placebo for Long COVID?

(MedPage Today) -- Nirmatrelvir-ritonavir (Paxlovid) wasn't any more effective at relieving long COVID symptoms than placebo, according to a large double-blind phase II trial. At 90 days in RECOVER-VITAL, symptoms meaningfully improved among the...

Is Paxlovid Any Better Than Placebo for Long COVID?

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 3 September →